Home > News > Pro-Pharmaceuticals' Abstract Published
June 5th, 2006
Pro-Pharmaceuticals' Abstract Published
Abstract:
Pro-Pharmaceuticals, Inc. (Amex: PRW), a developer of novel nanotechnology carbohydrate therapeutic compounds, today announced that its abstract, "A Bio-distribution Study of DAVANAT(R) " was published in The American Society of Cancer Oncology's (ASCO) 2006 Annual Meeting Proceedings. The ASCO Annual Meeting is being held in Atlanta, Georgia, June 2-6.
Source:
businesswire
Bookmark:
| Related News Press |
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||